ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,469.30
0.39%
Dow Jones
39,112.16
-0.76%
US Dollar vs MXN
18.07704
-0.27%
Brent Oil
84.655
0.56%
Bitcoin
61,625.00
-0.30%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Soleno Therapeutics Inc (SLNO)

  7. Soleno Therapeutics Inc (SLNO) Noticias

SLNO

Soleno Therapeutics (SLNO)

Soleno Therapeutics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:SLNO
FechaHoraFuenteTítuloSímboloCompañía
24/06/202416:18GlobeNewswire Inc.Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:SLNOSoleno Therapeutics Inc
10/06/202419:52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SLNOSoleno Therapeutics Inc
06/06/202415:29Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SLNOSoleno Therapeutics Inc
04/06/202407:00GlobeNewswire Inc.Soleno Therapeutics Set to Join Russell 3000® IndexNASDAQ:SLNOSoleno Therapeutics Inc
22/05/202415:05GlobeNewswire Inc.Soleno Therapeutics Announces Oral Presentation featuring DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome at ENDO 2024NASDAQ:SLNOSoleno Therapeutics Inc
22/05/202407:00GlobeNewswire Inc.Soleno Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:SLNOSoleno Therapeutics Inc
15/05/202407:00GlobeNewswire Inc.Soleno Therapeutics Stands with the Prader-Willi Syndrome CommunityNASDAQ:SLNOSoleno Therapeutics Inc
09/05/202415:31Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SLNOSoleno Therapeutics Inc
09/05/202415:05GlobeNewswire Inc.Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial ResultsNASDAQ:SLNOSoleno Therapeutics Inc
06/05/202415:58Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:SLNOSoleno Therapeutics Inc
02/05/202421:32GlobeNewswire Inc.Soleno Therapeutics Announces Pricing of Approximately $138 Million Public Offering Of Common StockNASDAQ:SLNOSoleno Therapeutics Inc
02/05/202415:01GlobeNewswire Inc.Soleno Therapeutics Announces Proposed Public Offering of Common StockNASDAQ:SLNOSoleno Therapeutics Inc
30/04/202407:00GlobeNewswire Inc.Soleno Therapeutics Announces Peer-Reviewed Publication of Data Comparing DCCR Treatment to the Natural History of Prader-Willi SyndromeNASDAQ:SLNOSoleno Therapeutics Inc
29/04/202407:00GlobeNewswire Inc.Soleno Therapeutics Receives Breakthrough Therapy Designation from U.S. FDA for DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome (PWS)NASDAQ:SLNOSoleno Therapeutics Inc
06/03/202415:05GlobeNewswire Inc.Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial ResultsNASDAQ:SLNOSoleno Therapeutics Inc
22/02/202407:00GlobeNewswire Inc.Soleno Therapeutics to Present at the TD Cowen 44th Annual Health Care ConferenceNASDAQ:SLNOSoleno Therapeutics Inc
31/01/202415:19Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:SLNOSoleno Therapeutics Inc
24/01/202407:00GlobeNewswire Inc.Soleno Therapeutics Strengthens Leadership Team with Key AppointmentsNASDAQ:SLNOSoleno Therapeutics Inc
02/01/202415:06Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNASDAQ:SLNOSoleno Therapeutics Inc
14/12/202316:09Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:SLNOSoleno Therapeutics Inc
07/11/202307:00GlobeNewswire Inc.Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial ResultsNASDAQ:SLNOSoleno Therapeutics Inc
06/11/202307:00GlobeNewswire Inc.Soleno Therapeutics Announces Peer-Reviewed Publication of Results from Long-Term Open-Label Study of DCCR in Prader-Willi SyndromeNASDAQ:SLNOSoleno Therapeutics Inc
31/10/202323:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SLNOSoleno Therapeutics Inc
20/10/202315:32Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:SLNOSoleno Therapeutics Inc
16/10/202315:30Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:SLNOSoleno Therapeutics Inc
12/10/202315:05Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:SLNOSoleno Therapeutics Inc
04/10/202317:16GlobeNewswire Inc.Correcting & Replacing -- Soleno Therapeutics Announces DCCR Data Presentation at the Foundation for Prader-Willi Research SymposiumNASDAQ:SLNOSoleno Therapeutics Inc
04/10/202315:05GlobeNewswire Inc.Soleno Therapeutics Announces DCCR Data Presentation at the Foundation for Prader-Willi Research SymposiumNASDAQ:SLNOSoleno Therapeutics Inc
04/10/202309:36Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:SLNOSoleno Therapeutics Inc
02/10/202315:05GlobeNewswire Inc.Soleno Therapeutics Announces Closing of Underwritten Public Offering of Common Stock and Concurrent Private Placement of Common Stock and Pre-Funded Warrants and Full Exercise of Underwriters’ Option to Purchase Additional SharesNASDAQ:SLNOSoleno Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:SLNO

Su Consulta Reciente

BIT
P1SR84
BNP Paribas Issuance
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados